Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2007
11/14/2007CN101072503A 3-cyclopropyl-4-(3-amino-2-methylbenzoyl)pyrazols and the use of the same as herbicides
11/14/2007CN101070317A Heterocyclic derivatives, composition containing same and method for pests control
11/14/2007CN101070316A Di-aryl acid derivatives as ppar receptor ligands
11/14/2007CN101070309A Substituted piperazines (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
11/14/2007CN101070304A Quinoline derivatives and their use as mycrobacterial inhibitors
11/14/2007CN100348592C 3,7,8-trisubstituted-5-hydrobenzo-gamma-pyranone compound and its preparation method
11/14/2007CN100348587C Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/14/2007CN100348585C Novel method of synthesising 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one derivatives and use thereof in the synthesis of ivabradine and the salts thereof for addition to a pharmaceutically acceptable aci
11/13/2007US7294644 CB 1 receptor inverse agonists
11/13/2007US7294637 Such as [1-(4-chloro-phenyl)-cyclobutyl]-(3-hydroxymethyl piperidin-1-yl)-methadone for treating cocaine and/or methamphetamine addiction
11/13/2007US7294634 Controlling cell proliferation; anticancer agents
11/13/2007US7294629 Drugs as enzyme inhibitors for tyrosine kinases and for treatment of psoriasis
11/13/2007US7294622 Lactams and uses thereof
11/13/2007CA2342804C Vending machine
11/13/2007CA2289013C Chemical process for the reduction of 1-substituted-3-hydroxymethyl-4-(4-fluorophenyl)tetrahydropyridines
11/13/2007CA2258243C 4,7-dichlororhodamine dyes
11/13/2007CA2248304C Surface modified carbonate materials
11/13/2007CA2213080C 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
11/08/2007WO2007127731A1 4-squarylpiperazine derivatives as antiviral agents
11/08/2007WO2007125351A1 Pyrimidine derivatives for the treatment of amyloid-related diseases
11/08/2007WO2007124617A1 Coumarin derivatives, their preparation methods and their pharmaceutic compositions and uses
11/08/2007WO2007124546A1 Integrase inhibitors 3
11/08/2007WO2007124545A1 Integrase inhibitors - 2
11/08/2007WO2007124544A1 Integrase inhibitors - 1
11/08/2007WO2007104783A3 1,4 -di substituted 3-cyano-pyridone derivatives and their use as positive mglur2-recept0r modulators
11/08/2007WO2007092854A3 2-AMINO-QUINOLINE DERIVATIVES USEFUL AS INHIBITORS OF β-SECRETASE (BACE)
11/08/2007WO2007084450A3 Cannibinoid receptor modulators
11/08/2007WO2007082098A3 6-(poly-substituted aryl)-4-aminopicolinates and their use as herbicides
11/08/2007US20070259944 Amides such as 5-(3-Nitrophenyl)-1,3-dihydro-indol-2-one, used as antiprogesterones, contraceptives, for hormone replacement therapy during menopause and as anticarcinogenic agents
11/08/2007US20070259942 Indolone derivatives like N2-[2-(5-Methyl-1H-3-indolyl)ethyl]-N4-(4-methylphenyl)-6-(1-piperidinyl)-2,4-pyrimidinediamine; galanin-type receptors; antidepressants; anxiolytic agents
11/08/2007US20070259924 such as 5-Chloro-N-((1-(4-(2-oxopyridin-1(2H)-yl)phenyl)-1H-imidazol-4-yl)methyl)thiophene-2-carboxamide, used to prevent or treat conditions characterized by undesired thrombosis and inhibiting the coagulation of blood samples
11/08/2007US20070259922 Aryl, aryloxy, alkyloxy substituted 1H-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
11/08/2007US20070259900 Polymorphs
11/08/2007US20070259879 Piperazine and piperidine biaryl derivatives
11/08/2007US20070259877 Piperazine Derivatives Useful for the Treatment of Gastrointestinal Disorders
11/08/2007US20070259868 phosphodiesterase PDE4 inhibitor; preparing claimed 3-(dialkoxy)phenyl-4-aminopyran intermediate from the claimed 4-oxo compound starting with hydrobromination of the corresponding phenylacetylene; antiinflammatory for airways and skin; respiratory; bronchodilator
11/08/2007US20070259863 Arylphenylamino-,Arylphenylamide-, and Arylphenylether-Sulfide Derivatives
11/08/2007US20070259849 Azine-Carboxamides as Anti-Cancer Agents
11/08/2007US20070259286 Reversible Piezochromic Systems
11/08/2007US20070258905 Contrast Agents Endowed with High Relaxivity for Use in Magnetic Resonance Imaging (Mri) Which Contain a Chelating Moiety with Polyhydroxylated Substituents
11/08/2007DE60021370C5 Piperazinderivate verwendbar als ccr5 antagonisten Piperazine derivatives useful as antagonists ccr5
11/08/2007CA2650389A1 Pyrimidine derivatives for the treatment of amyloid-related diseases
11/08/2007CA2649995A1 Amino-ethyl-amino-aryl (aeaa) compounds and their use
11/08/2007CA2647338A1 Integrase inhibitors-3
11/07/2007EP1852432A1 Nitrogenous heterocyclic compound and medicinal use thereof
11/07/2007EP1852422A2 Nitrosated and nitorsylated alpha-andrenergic receptor antagonist compounds, compositions and their uses
11/07/2007EP1851227A1 An efficient and stereoselective process for large scale synthesis of 3-(r)-3- (2,3-dihydrobenzofuran-5-yl)-1,2,3,4- tetrahydropyrrolo{3,4-b}quinolin-9-one
11/07/2007EP1851213A2 Mitotic kinesin inhibitors
11/07/2007EP1851204A1 Naphthalene derivatives as modulators of the glucocorticoid receptor
11/07/2007EP1851202A1 Pyridyl acetic acid compounds
11/07/2007EP1851199A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
11/07/2007EP1664033B1 9,10-alpha,alpha-oh-taxane analogs and methods for production the reof
11/07/2007EP1613597B1 6-substituted nicotinamide derivatives as opioid receptor antagonists
11/07/2007EP1539712B1 Pyrimidine derivatives and their use as cb2 modulators
11/07/2007EP1192151B1 Anilinoquinazolines as protein tyrosine kinase inhibitors
11/07/2007CN101068794A Quinazolines useful as modulators of ion channels
11/07/2007CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
11/07/2007CN101066970A Method for preparing medicine composition containing 1,3 oxathiolane nucleoside analogue
11/07/2007CN101066969A Prepn process of quinamine alcohol
11/07/2007CN100347169C 喹唑啉衍生物 Quinazoline derivatives
11/07/2007CN100347161C Pna单体和前体 Pna monomers and precursors
11/07/2007CN100347158C Bicyclic compound
11/07/2007CN100346786C Substituted benzimidazole compounds and their use for the treatment of cancer
11/06/2007USRE39916 Compounds that modulate PPAR activity and methods for their preparation
11/06/2007US7291644 For therapy and prophylaxis of allergic disorder, diseases accompanied with itching, secondary diseases generated by behaviors caused by itching, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, pleuritis complicated by rheumatoid arthritis, cerebrovascular disease
11/06/2007US7291641 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
11/06/2007US7291632 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-HT1F agonists
11/06/2007US7291629 Neurotrophin antagonist compositions
11/06/2007US7291624 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/06/2007US7291619 Melanocortin receptor agonists
11/06/2007US7291616 Such as 6(5-chloro-2-methoxyphenyl)-N-(4-chlorophenyl)-(1,3,5) triazine-2,4-diamine for inhibition of lysophosphatidic acid acyltransferase (LLPAAT-SS); antitumor agents
11/06/2007US7291615 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents
11/06/2007US7291431 Polymeric charge transport compound that is formed by reacting a functionality in a polymeric binder and an epoxy group contained in a hydrazone compound that also contains a diarylamine group, e.g., p-(Diphenylamino)benzaldehyde-N-2,3-epoxypropyl-N-Phenylhydrazone
11/06/2007CA2267322C Pde iv inhibiting 2-cyanoiminoimidazole derivatives
11/06/2007CA2241666C Tricyclic compounds, their production and use
11/01/2007WO2007124329A1 Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/01/2007WO2007124321A1 Inhibitors of c-fms kinase
11/01/2007WO2007124319A1 Inhibitors of c-fms kinase
11/01/2007WO2007124288A1 Indazole compounds and methods for inhibition of cdc7
11/01/2007WO2007123516A1 C-fms kinase inhibitors
11/01/2007WO2007122755A1 Salt of sulfinylbenzimidazole compound, and crystal and amorphous form thereof
11/01/2007WO2007122686A1 Benzimidazole compounds
11/01/2007WO2007122634A2 Pyrimidinediones as tyrosine kinase inhibitors
11/01/2007WO2007122482A1 Fused phenyl amido heterocyclic compounds for the prevention and treatment of glucokinase-mediated diseases
11/01/2007WO2007122333A2 Process for preparing disulphides and thiosulphinates and compounds prepared
11/01/2007WO2007122219A1 3- (aminomethyliden) 2-indolinone derivatives and their use as cell proliferation inhibitors
11/01/2007WO2007122173A1 Substituted pyrazinone derivatives for use as a medicine
11/01/2007WO2007122103A1 Diazepan derivatives modulators of chemokine receptors
11/01/2007WO2007121687A1 4-methyl-1h-diaryl pyrazole derivatives and their uses as medicament
11/01/2007WO2007093880A3 Novel pyrone-indole derivatives and process for their preparation
11/01/2007WO2007047146A3 Inhibitors of viral replication
11/01/2007WO2007030589A3 Pharmaceutical dosage forms and compositions comprising lecoztan
11/01/2007WO2006097460A8 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them
11/01/2007US20070255060 Process for the Manufacture of the Calcium Salt of Rosuvastatin (E)-7-'4-(4-Fluorophenyl)-6-Isopropyl-2-'Methyl (Methylsulfonyl) Amino ! Pyrmidin -5-Yl! (3R, 5S)-3,5-Dihydroxyhept-6-Enoic Acid and Crystalline Intermediates Thereof
11/01/2007US20070254940 1,5 And 3,6- substituted indole compounds having NOS inhibitory activity
11/01/2007US20070254935 Pyrazole and imidazole compounds and uses thereof
11/01/2007US20070254920 Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
11/01/2007US20070254919 Aroyl-O-Piperidine Derivatives for the Treatment of Diabetes-Related Problems
11/01/2007US20070254913 3-Ethyl-6-(1-ethyl-1H-pyrazol-5-yl)-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridine; adenosine monophosphate activator; antiinflammatory agent, antidepressant, antiallergen, cognition activator, neurodegenerative diseases; arthritis, Alzheimer's disease, schizophrenia, Parkinson disease
11/01/2007US20070254874 gastrointestinal disorders, urinary tract disorders such as hyperactive bladder, and cardiovascular disorders without side effects related to CNS activity; acid moiety makes drug unable to cross the blood-brain barrier; carboxy, phosphonic, sulfonic, or phosphoric acid derivative of piboserod (DDL-6001)
1 ... 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 ... 694